Stem cell factor protects c-kit+ human primary erythroid cells from apoptosis.

Area of Science:

• Hematopoiesis and Stem Cell Biology
• Cellular Signaling and Apoptosis

Background:

• Stem cell factor (SCF) is known to promote survival in primary cultured human erythroid colony-forming cells (ECFC).
• The heterogeneity of ECFC populations can complicate the interpretation of SCF's effects.
• Purification of specific ECFC subsets is crucial for understanding precise cellular mechanisms.

Purpose of the Study:

• To investigate the specific anti-apoptotic effects of SCF on purified c-kit+ ECFC.
• To elucidate the molecular mechanisms underlying SCF-mediated cell survival in human erythroid cells.
• To determine the role of Src family kinases and Akt signaling in SCF's protective function.

Main Methods:

• Purification of Glycophorin A+ (GPA+) c-kit+ cells from human CD34+ derived ECFC.
• Assessment of apoptosis using DNA fragmentation assays (ELISA, gel electrophoresis, annexin V labeling) in the presence/absence of SCF and erythropoietin (EPO).
• Analysis of SCF-induced signaling pathways, including Src family kinase inhibition (PP2) and Akt phosphorylation via Western blotting.

Main Results:

• SCF and EPO significantly prevented rapid DNA fragmentation in purified GPA+c-kit+ cells within 4-6 hours.
• Non-erythroid cells and GPA+c-kit- cells did not exhibit significant DNA fragmentation within 24 hours.
• The Src family kinase inhibitor PP2, but not PP3, reversed SCF's anti-apoptotic effects and inhibited SCF-induced Akt phosphorylation.

Conclusions:

• SCF confers significant protection against apoptosis in purified human GPA+c-kit+ cells.
• Kit-mediated Src kinase activation plays a critical role in SCF's protective mechanism.
• This pathway is essential for SCF-induced Akt activation and subsequent cell survival.